Asxl2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-protein
| Protein Name | ASXL2 |
| Gene | ASXL2 |
| UniProt ID | Q76N89 |
| PDB Structure | Not available |
| Molecular Weight | ~160 kDa |
| Subcellular Localization | Nucleus (chromatin) |
| Protein Family | ASXL family |
::
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
ASXL2 is a 1588-amino acid protein with high homology to ASXL1. It contains an ASXH domain and multiple protein-protein interaction motifs that allow it to function as a scaffold for chromatin-modifying complexes.
ASXL2 functions as a transcriptional regulator through recruitment of epigenetic modifiers. Like ASXL1, it interacts with PRC2 and other chromatin-modifying complexes to regulate gene expression during development and in differentiated tissues 1.
De novo mutations in ASXL2 cause autism spectrum disorder through disruption of neural development and synaptic function. ASXL2 deficiency affects genes involved in synaptic plasticity and neuronal connectivity 2.
ASXL2 variants contribute to schizophrenia risk by altering epigenetic regulation of neurotransmitter-related genes and neural circuit development 3.
The study of Asxl2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.